PRR5L
Basic information
Region (hg38): 11:36296288-36465204
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PRR5L gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 23 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 23 | 1 | 5 |
Variants in PRR5L
This is a list of pathogenic ClinVar variants found in the PRR5L region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-36401129-G-A | Benign (Dec 20, 2018) | |||
11-36401137-G-A | not specified | Uncertain significance (Oct 14, 2023) | ||
11-36401152-G-T | not specified | Uncertain significance (May 28, 2024) | ||
11-36401166-G-T | not specified | Uncertain significance (Feb 13, 2024) | ||
11-36401243-C-A | not specified | Uncertain significance (Dec 16, 2021) | ||
11-36401245-C-T | not specified | Uncertain significance (Mar 20, 2023) | ||
11-36403350-G-A | not specified | Uncertain significance (Oct 20, 2023) | ||
11-36403367-C-T | Benign (Jul 23, 2018) | |||
11-36431865-G-A | not specified | Uncertain significance (Dec 15, 2023) | ||
11-36437394-G-T | not specified | Uncertain significance (Jun 24, 2022) | ||
11-36437396-A-G | not specified | Uncertain significance (Jun 28, 2024) | ||
11-36437447-A-G | Benign (Apr 19, 2019) | |||
11-36446363-G-A | not specified | Uncertain significance (Dec 09, 2023) | ||
11-36451290-G-A | not specified | Uncertain significance (Mar 02, 2023) | ||
11-36451302-G-C | not specified | Uncertain significance (Feb 27, 2023) | ||
11-36451324-C-T | not specified | Uncertain significance (Jul 05, 2023) | ||
11-36462348-G-A | not specified | Uncertain significance (Aug 08, 2023) | ||
11-36462352-C-T | not specified | Likely benign (Feb 05, 2024) | ||
11-36462395-C-T | not specified | Uncertain significance (Mar 31, 2023) | ||
11-36462413-C-T | not specified | Uncertain significance (Dec 28, 2023) | ||
11-36462462-A-C | not specified | Uncertain significance (Mar 19, 2024) | ||
11-36462488-G-C | not specified | Uncertain significance (Aug 04, 2024) | ||
11-36462518-T-G | not specified | Uncertain significance (Sep 22, 2023) | ||
11-36462520-G-A | Benign (Dec 20, 2018) | |||
11-36462565-G-T | Benign (Dec 20, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PRR5L | protein_coding | protein_coding | ENST00000378867 | 8 | 168917 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0655 | 0.932 | 125734 | 0 | 14 | 125748 | 0.0000557 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.23 | 172 | 224 | 0.768 | 0.0000140 | 2366 |
Missense in Polyphen | 60 | 95.952 | 0.62531 | 1056 | ||
Synonymous | 0.161 | 92 | 94.0 | 0.979 | 0.00000584 | 763 |
Loss of Function | 2.62 | 5 | 16.5 | 0.303 | 8.73e-7 | 179 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000987 | 0.0000967 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Associates with the mTORC2 complex that regulates cellular processes including survival and organization of the cytoskeleton (PubMed:17461779). Regulates the activity of the mTORC2 complex in a substrate-specific manner preventing for instance the specific phosphorylation of PKCs and thereby controlling cell migration (PubMed:22609986). Plays a role in the stimulation of ZFP36-mediated mRNA decay of several ZFP36- associated mRNAs, such as TNF-alpha and GM-CSF, in response to stress (PubMed:21964062). Required for ZFP36 localization to cytoplasmic stress granule (SG) and P-body (PB) in response to stress (PubMed:21964062). {ECO:0000269|PubMed:17461779, ECO:0000269|PubMed:21964062, ECO:0000269|PubMed:22609986}.;
- Pathway
- Target Of Rapamycin (TOR) Signaling
(Consensus)
Intolerance Scores
- loftool
- 0.240
- rvis_EVS
- 0.18
- rvis_percentile_EVS
- 66.07
Haploinsufficiency Scores
- pHI
- hipred
- Y
- hipred_score
- 0.590
- ghis
- 0.443
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.943
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Prr5l
- Phenotype
Gene ontology
- Biological process
- negative regulation of protein phosphorylation;positive regulation of protein phosphorylation;negative regulation of signal transduction;regulation of fibroblast migration;positive regulation of phosphatidylinositol 3-kinase signaling;cellular response to oxidative stress;TORC2 signaling;positive regulation of mRNA catabolic process;positive regulation of intracellular protein transport
- Cellular component
- TORC2 complex
- Molecular function
- protein binding;ubiquitin protein ligase binding